XORTX Therapeutics XRTX
NASDAQ XRTX
$1.73 +0.04 (+2.37%)
At close: Oct 1, 2026 · 4:00 PM EDT

XORTX Therapeutics (XRTX) Net Equity Issued and Repurchased (2020 - 2021)

Updated

XORTX Therapeutics (XRTX) reported Net Equity Issued and Repurchased of -$4.79 million for the quarter ended Dec 31, 2021, compared with -$1.22 million a year earlier.

Analysis

XORTX Therapeutics (XRTX) Net Equity Issued and Repurchased (2020 - 2021) Analysis & Trends

For the year ended Dec 31, 2021, XORTX Therapeutics posted Net Equity Issued and Repurchased of $66,502, down 90.1% from the prior year.

  • By year, Net Equity Issued and Repurchased came in at $671,832 in the year ended Dec 31, 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 43.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 6.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 9.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 47.70 Mn
10 XORTX Therapeutics 1.60 Mn -1.70 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 -4.79 Mn
Mar 31, 2021 4.84 Mn
Dec 31, 2020 -1.22 Mn
API Access

XORTX Therapeutics Net Equity Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=XRTX&period=max&api_key=YOUR_API_KEY